Marseille 2007
| Abstract #696 - Innovations in HIV Testing and Implications in the STD Clinic Setting | ||||
|
Session: 9.3: Evolution of HIV prevention in STD Clinic Settings (Parallel) on Monday @ 11.00-12.30 in Auditorium/Overflow Chaired by Kees Rietmeijer, John Douglas Authors: Presenting Author: Dr Cornelis Rietmeijer - Denver Health, United States |
||||
| Additional Authors: | ||||
| Aim: Issue: Due to developments largely set in motion by the availability and effectiveness of highly-active antiretroviral therapy, a shift in prevention focus from HIV-uninfected to HIV-infected populations has occurred. As a result, enhanced efforts are underway to identify those who are HIV-infected through enhanced HIV testing programs, and to link them to care and prevention services. Historically, STD clinics have played an important role in providing HIV testing to high-risk populations and a number of recent innovations have increased the ability to identify previously undiagnosed HIV-infected patients in these and other clinical settings. | ||||
| Method / Issue: Project: Using experiences at the Denver Metro Health (STD) Clinic as an example, advantages and disadvantages of rapid vs. traditional (non-rapid) test technologies and opt-in vs. opt-out testing will be discussed. Attention will be given to the potential downsides of one-session (with rapid testing) vs two-session (with traditional testing) prevention counseling. The use of viral RNA testing on pooled blood specimens to identify serologically negative patients with acute HIV infection will also be discussed. The presentation will conclude by stressing the importance of presenting newly-diagnosed HIV-infected persons with care and prevention options. | ||||
| Discussion: Lessons Learned: New testing methods and technologies can increase the uptake of HIV testing in STD and other clinical settings and thus enhance the identification of persons with HIV infection | ||||
| Go Back | ||||
